$CDLX

Lynton Nicholas Hollmeyer sold $9K of CDLX

Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) sold 2,151 shares of Cardlytics, Inc. (CDLX) at $4.40 on 2026-07-02.

Original reporting
SEC EDGAR · Lynton Nicholas Hollmeyer
Published Jul 6, 2026, 9:39 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CDLX
Neutral
high confidence
Mentioned
$CDLX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDLXNeutralLow
01

Why it matters

The disclosure provides confirmation of an officer’s open-market sale but does not include any new company performance, guidance, legal/regulatory, or deal information.

02

Market read

Primarily a sentiment/positioning datapoint; likely limited trading impact given small transaction size and lack of fundamental catalysts.

03

What to watch

Insider sales can be driven by taxes, diversification, or pre-planned personal liquidity; without additional context, the signal-to-noise for trading is low.

Relevance 3/10Novelty 2/10Timing: Filed 2026-07-06; reflects sale executed 2026-07-02.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Cardlytics, Inc.

Company-level read

Ticker impact

$CDLXNeutralHigh confidence
Context

Form 4 shows Cardlytics’ Chief Legal & Privacy Officer sold 2,151 shares on 2026-07-02 at $4.3950 for $9,453.64.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived.

Evidence & confidence

The filing is a small, non-10b5-1 sale by an officer with limited disclosed economic significance versus company size, and no new company-specific operational/regulatory catalyst is provided.

Market effects

No clear sector read-through; this is an isolated insider transaction with no accompanying guidance or regulatory development.

None indicated.

None indicated.

Counterpoint

Because the sale is not explicitly tied to a 10b5-1 plan, some traders may interpret it as a near-term liquidity need or reduced confidence, but the disclosed value is modest.

Key entities

  • Cardlytics, Inc.

    Subject of the Form 4 insider transaction; ticker CDLX.

  • Lynton Nicholas Hollmeyer

    Chief Legal & Privacy Officer who sold 2,151 shares on 2026-07-02.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDLXMedAI 8/10

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics (CDLX) reported Q2 2026 results on an earnings call. Revenue was $36.9M, down 36% YoY, with billings $65.5M (-34%) and adjusted contribution $21.3M (-32%). Net loss was $14.9M. Q3 2026 guidance: billings $61M-$67M, revenue $34M-$39M, adjusted EBITDA $0M-$3M. Cash was $28M.

$CDLXMedAI 8/10

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

$CDLXMed

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million

$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).